The new Stenocare medical cannabis oil product is called “AD 10-10 STENOCARE Extrakt”. The new Stenocare product will be reimbursed by the insurance companies which allows more patients to have access to treatment with the new Stenocare product. he new Stenocare medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for prescription-based sales to German patients. With this, Stenocare is now entering Germany, the by far largest European market for medical cannabis. About the German cannabis market: The medical cannabis industry in Germany includes +200.000 patients (out of 87 mill citizens) and projected sales of Euro 1 billion in 2027.
he new Stenocare medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for prescription-based sales to German patients. With this, Stenocare is now entering Germany, the by far largest European market for medical cannabis. The new product will be available for patients in Germany as soon as possible, expected during August 2023.
Strong German partner in place and product approved and ready: Stenocare now expands into Germany with a local partner, ADREX Pharma, that specializes in development, production and marketing of medical cannabis products. The two companies...
Read the full article @ Cannabis Law Report